| Graphene quantum dots: Synthesis, characterization, cell viability, genotoxicity for biomedical applications B Şenel, N Demir, G Büyükköroğlu, M Yıldız Saudi Pharmaceutical Journal 27 (6), 846-858, 2019 | 99 | 2019 |
| Chitosan nanoparticles for ocular delivery of cyclosporine A E Başaran, E Yenilmez, MS Berkman, G Büyükköroğlu, Y Yazan Journal of microencapsulation 31 (1), 49-57, 2014 | 87 | 2014 |
| Techniques for protein analysis G Büyükköroğlu, DD Dora, F Özdemir, C Hızel Omics technologies and bio-engineering, 317-351, 2018 | 66 | 2018 |
| Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer G Büyükköroğlu, B Şenel, E Başaran, E Yenilmez, Y Yazan European Journal of Pharmaceutics and Biopharmaceutics 109, 174-183, 2016 | 66 | 2016 |
| Solid lipid and chitosan particulate systems for delivery of siRNA B Şenel, G Büyükköroğlu, Y Yazan Die Pharmazie-An International Journal of Pharmaceutical Sciences 70 (11 …, 2015 | 24 | 2015 |
| Vaginal suppositories with siRNA and paclitaxel-incorporated solid lipid nanoparticles for cervical cancer: Preparation and in vitro evaluation G Büyükköroğlu, B Şenel, E Yenilmez RNA Interference and Cancer Therapy: Methods and Protocols, 303-328, 2019 | 16 | 2019 |
| Formulation and in vitro evaluation of moxifloxacin hydrochloride-loaded polymeric nanoparticles for ocular application G YURTDAŞ-KIRIMLIOĞLU, Ö Sinan, G BÜYÜKKÖROĞLU, Y Yazan Latin American Journal of Pharmacy 37 (9), 1850-62, 2018 | 15 | 2018 |
| The simultaneous delivery of paclitaxel and Herceptin® using solid lipid nanoparticles: in vitro evaluation G Büyükköroğlu, B Şenel, S Gezgin, T Dinh Journal of Drug Delivery Science and Technology 35, 98-105, 2016 | 15 | 2016 |
| Moxifloxacin hydrochloride-loaded Eudragit® RL 100 and Kollidon® SR based nanoparticles: Formulation, in vitro characterization and cytotoxicity GY Kırımlıoğlu, S Özer, G Büyükköroğlu, Y Yazan Combinatorial Chemistry & High Throughput Screening 24 (3), 328-341, 2021 | 11 | 2021 |
| Omics technologies and bio-engineering G Büyükköroğlu, DD Dora, F Özdemir, C Hızel Towards Improving Quality of Life, 317-351, 2018 | 11 | 2018 |
| Preparation and physicochemical characterizations of solid lipid nanoparticles containing DOTAP $^® $ for DNA delivery G BÜYÜKKÖROĞLU, EY Yazan, AF ÖNER Turkish Journal of Chemistry 39 (5), 1012-1024, 2015 | 11 | 2015 |
| Engineering monoclonal antibodies: Production and applications G Büyükköroğlu, B Şenel Omics Technologies and Bio-Engineering, 353-389, 2018 | 10 | 2018 |
| Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy G Büyükköroğlu, B Şenel, E Başaran, S Gezgin Tropical Journal of Pharmaceutical Research 15 (5), 895-903, 2016 | 8 | 2016 |
| Spray-dried ketoprofen lysine-incorporated PLGA nanoparticles; formulation, characterization, evaluation and cytotoxic profile A Elmaskaya, A Öztürk, G Büyükköroğlu, E Yenilmez Indian Journal of Pharmaceutical Sciences 81 (4), 2019 | 7 | 2019 |
| Development of solid lipid nanoparticles as gene delivery system G Büyükköroğlu Turk J Pharm Sci 13 (2), 169-181, 2016 | 7 | 2016 |
| HDL-chitosan nanoparticles for siRNA delivery as an SR-B1 receptor targeted system R Masimov, G Büyükköroğlu Combinatorial Chemistry & High Throughput Screening 26 (14), 2541, 2023 | 5 | 2023 |
| Applications of lipidic and polymeric nanoparticles for siRNA delivery B Şenel, G Büyükköroğlu Antisense Therapy, 2019 | 4 | 2019 |
| Preparation and In Vitro Evaluation of DNA-Bonded Polymeric Nanoparticles as New Approach for Transcutaneous Vaccination G Buyukkoroglu, B Senel, RB Karabacak Latin American Journal of Pharmacy 36 (4), 730-739, 2017 | 3 | 2017 |
| Preparation and in vitro evaluation of dna-bonded polymeric nanoparticles as new approach for transcutaneous vaccination G Büyükköroğlu, B Şenel, RB Karabacak Lat Am J Pharm 36, 730-739, 2017 | 3 | 2017 |
| Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy B Şenel, E Basaran, E Akyıl, UM Güven, G Büyükköroğlu ACS omega 9 (10), 11671-11685, 2024 | 2 | 2024 |
